(Q34384772)

1 August 2017

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid (English)

1 reference

1 August 2017

0 references

Beal MF

1

1 reference

1 August 2017

Kowall NW

2

1 reference

1 August 2017

Ellison DW

3

1 reference

1 August 2017

Mazurek MF

4

1 reference

1 August 2017

Swartz KJ

5

1 reference

1 August 2017

Martin JB

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

1 August 2017

4

1 reference

inferred from page(s)

published in

Nature

1 reference

1 August 2017

321

1 reference

1 August 2017

168-171

1 reference

1 August 2017

6066

1 reference

https://scigraph.springernature.com/pub.10.1038/321168a0

1 August 2017

0 references

cites work

Huntington's disease: New approaches to an old problem: The Robert Wartenberg Lecture

1 reference

Somatostatin is increased in the nucleus accumbens in Huntington's disease

21 January 2018

1 reference

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

21 January 2018

1 reference

7 January 2021

Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids

1 reference

7 January 2021

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

1 reference

7 January 2021

II. Excitotoxic models for neurodegenerative disorders

1 reference

7 January 2021

Identification of quinolinic acid in rat and human brain tissue

1 reference

7 January 2021

Somatostatin is increased in the basal ganglia in Huntington disease

1 reference

7 January 2021

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

1 reference

7 January 2021

Selective sparing of a class of striatal neurons in Huntington's disease

1 reference

7 January 2021

Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease

1 reference

7 January 2021

A polymorphic DNA marker genetically linked to Huntington's disease

1 reference

7 January 2021

Effects of lesions on somatostatin-like immunoreactivity in the rat striatum

1 reference

7 January 2021

Excitotoxin lesions do not mimic the alteration of somatostatin in Huntington's disease

1 reference

7 January 2021

The effect of somatostatin on striatal catecholamines

1 reference

7 January 2021

Determination of gamma-aminobutyric and glutamic acids in rat brain by liquid chromatography with electrochemical detection

1 reference

7 January 2021

Temporal patterns of somatostatin immunoreactivity in the cerebrospinal fluid of the rhesus monkey: effect of environmental lighting

1 reference

7 January 2021

Fluorometric assay of proteins in the nanogram range

1 reference

7 January 2021

Regional somatostatin distribution in the rat striatum

1 reference

7 January 2021

Effects of lesions in the amygdala and periventricular hypothalamus on striatal somatostatin-like immunoreactivity.

1 reference

7 January 2021

Somatostatin precursor in the rat striatum: changes after local injection of kainic acid.

1 reference

7 January 2021

Topography of nicotinamide adenine dinucleotide phosphate-diaphorase staining neurons in rat striatum

1 reference

7 January 2021

Histochemical demonstration of separate populations of somatostatin and cholinergic neurons in the rat striatum

1 reference

7 January 2021

NADPH-diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities

1 reference

7 January 2021

Differential effect of kainic acid on somatostatin, GABAergic and cholinergic neurons in the rat striatum.

1 reference

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

7 January 2021

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

1 reference

7 January 2021

Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo.

1 reference

7 January 2021

THE SOLITARY ACTIVE CELLS. HISTOCHEMICAL DEMONSTRATION OF DAMAGE-RESISTANT NERVE CELLS WITH A TPN-DIAPHORASE REACTION.

1 reference

7 January 2021

Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders.

1 reference

7 January 2021

Identifiers

DOI

10.1038/321168A0

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference